Technologies

InnoCore develops and manufactures injectable drug delivery products that enable sustained release of a wide range of compounds, including proteins, peptides and small molecules. Using our SynBiosys® and InGell® biodegradable polymer platforms we offer optimal control over the release kinetics and bioactivity of biological therapeutics. 

• API Visit
• Polymer
  technologies Visit
• Dosage
  forms Visit
• Sustained
  release Visit

	Micro spheres	Implants	Coating	Gels	In situ forming depots
Small  molecules	Our solution: SynBiosys®			Our solution: InGell®	Our solution: SynBiosys®
Peptides
Proteins				In development	In development
Oligonucleotides
Other	Contact us to discuss the possibilities

 

InnoCore takes products from early pre-clinical development into the clinic, as an extension of your R&D lab, by providing formulation development, process development, optimization and upscaling. Our solutions are applied to a variety of therapeutic areas such as Cardiology, Oncology, Ophthalmology, Osteoarthritis, Urology, Pain, Diabetes, CNS, Infectious diseases and Immunology. Our long-acting injectable drug delivery formulations can be applied for parenteral drug delivery, as well as for intramuscular injections, subcutaneous injections or injections into joints. With our 20 years of formulation experience, we are optimally suited to design your pharma injectables.